Condition: Crohn's Disease · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants with Crohn's Disease (CD) at the end of maintenance therapy (Week 52) among participants who were in clinical response to guselkumab at Week 12.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Cedars Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Connecticut Children's Medical Center | Hartford, Connecticut, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Active Not Recruiting |
| Children's Center for Digestive Health Care | Atlanta, Georgia, United States | Recruiting |
| Riley Hospital for Children | Indianapolis, Indiana, United States | Recruiting |
| Boston Childrens Hospital | Boston, Massachusetts, United States | Recruiting |
| Goryeb Children's Hospital | Morristown, New Jersey, United States | Recruiting |
| Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center | New York, New York, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | Recruiting |
| Columbia University Medical Center | New York, New York, United States | Recruiting |
| The Children's Medical Center of Dayton | Dayton, Ohio, United States | Completed |
| Children's Hospital of Philadelphia | Philadelphia, Pennsylvania, United States | Recruiting |
+ 73 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05923073